Subgroup |
| N | BRCA1/2 cases versus population-based cases | BRCA1/2 cases versus hospital-based cases | |||
Unadjusted | Adjusted1 | Unadjusted | Adjusted1 | ||||
OR (95%-CI) | OR (95%-CI) | OR (95%-CI) | OR (95%-CI) | ||||
| Cases stratified by nodal status | ||||||
BRCA 1 | Negative | 223 | 8.8 (6.4 - 12.1) | 1.9 (1.3 - 2.7)* | 8.8 (6.2 - 12.4) | 2.5 (1.7 - 3.8)* | |
Positive | 115 | 9.6 (5.9 - 15.6) | 4.3 (2.4 - 7.6)* | 6.3 (3.9 - 10.2) | 2.7 (1.4 - 5.3)* | ||
BRCA 2 | Negative | 49 | 2.6 (1.0 - 6.6) | 0.9 (0.3 - 2.4) | 2.6 (1.0 - 6.6) | 1.2 (0.5 - 3.4) | |
Positive | 56 | 9.3 (4.7 - 18.4) | 4.4 (2.0 - 9.7)* | 6.1 (3.1 - 12.1) | 2.7 (1.1 - 6.5)* | ||
ER-negative only BRCA 1/2 combined | Negative | 142 | 4.6 (3.1 - 6.8) | 2.0 (1.3 - 3.1)* | 24.3 (15.2 - 38.9) | xb | |
Positive | 65 | 8.4 (4.1 - 17.1) | 3.8 (1.8 - 8.3)* | 8.4 (4.1 - 17.0) | 2.6 (1.0 - 6.7) | ||
| Cases stratified by age at breast cancer diagnosis | ||||||
BRCA 1 | <35 | 108 | 1.6 (1.1 - 2.5) | 3.2 (1.8 - 5.8)* | 1.1 (0.7 - 1.7) | 2.4 (1.2 - 4.7)* | |
35 - 52 | 205 | 1.6 (1.2 - 2.2) | 2.5 (1.8 - 3.6)* | 1.0 (0.8 - 1.3) | 2.5 (1.6 - 3.7)* | ||
>52 | 44 | 5.4 (2.7 - 10.7) | 3.7 (1.7 - 8.0)* | 6.0 (3 - 12.1) | 7.8 (3.5 - 17.7)* | ||
BRCA 2 | <35 | 16 | 1.2 (0.4 - 3.2) | 1.0 (0.3 - 3.3) | 0.8 (0.3 - 2.2) | 0.3 (0.1 - 1.1) | |
35 - 52 | 76 | 2.3 (1.5 - 3.6) | 2.5 (1.4 - 4.5)* | 1.4 (0.9 - 2.2) | 1.9 (1.0 - 3.7) | ||
>52 | 19 | 5.4 (2.7 -10.7) | 3.5 (1.0 - 12.2) | 4.8 (1.6 - 14.6) | 7.4 (2.1 - 26.0)* | ||
ER-negative only BRCA 1/2 combined | <35 | 69 | 2.0 (1.1 - 3.6) | 3.8 (1.8 - 8.2)* | 1.3 (0.7 - 2.5) | 3.8 (1.2 - 12.1)* | |
35 - 52 | 122 | 1.5 (1.0 - 2.2) | 2.1 (1.3 - 3.3)* | 1.3 (0.9 - 1.8) | 4.1 (2.3 - 7.3)* | ||
>52 | 20 | 2.4 (0.9 - 6.2) | 2.7 (1.0 - 7.7) | 8.6 (3.2 - 22.8) | 39.1 (8.9 - 173)* | ||
| Cases stratified by year of diagnosis and nodal status | ||||||
BRCA 1(only grade 3 tumours included) | ≤1995 | Negative | 64 | 2.6 (0.8 - 9.0) | x2 | 1.9 (0.6 - 5.9) | x2 |
Positive | 28 | 11.2 (4.1-30.3) | 10.3 (2.3 - 46.7)* | 7.1 (2.7 - 18.9) | 8.6 (1.8 - 40.6)* | ||
>1995 | Negative | 68 | 7.8 (4.5 - 13.5) | x2 | 4.3 (2.4 - 7.8) | 2.8 (1.5 - 5.2)* | |
Positive | 37 | 12.9 (3.9 - 42.3) | 6.6 (1.9 - 22.3)* | 6.7 (2 - 22.2) | x2 | ||
BRCA 2b |
|
|
|
|
|
|
|
ER-negative only BRCA 1/2 combined | ≤1995 | Negative | 62 | 4.5 (1.1 - 18.3) | 1.2 (0.2 - 5.9) | 4.8 (1.3 - 18.2) | x2 |
Positive | 27 | 8.5 (3.2 - 22.9) | 3.8 (1.1 - 13.0)* | 7.0 (2.6 - 18.5) | 1.9 (0.5 - 7.1) | ||
>1995 | Negative | 80 | 5.8 (3.5 - 9.6) | 3.0 (1.7 - 5.2)* | 38.8 (21.5 - 70.2) | x2 | |
Positive | 38 | 8.3 (2.9 - 23.7) | 5.0 (1.7 - 14.9)* | 9.9 (3.5 - 28.1) | x2 |